Henan Taloph Pharmaceutical Stock Co Ltd Capital Reinvestment Ratio
Henan Taloph Pharmaceutical Stock Co Ltd capital reinvestment ratio. Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥22.69 Million) in capital expenditures (CN¥5.45 Million). Check Henan Taloph Pharmaceutical Stock Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Capital reinvestment ratio of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. This chart tracks Henan Taloph Pharmaceutical Stock Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Also explore net asset growth rate of Henan Taloph Pharmaceutical Stock Co Ltd to track the company's year-over-year net asset growth rate.
Henan Taloph Pharmaceutical Stock Co Ltd Capital Reinvestment Ratio by Year (1998–2025)
Henan Taloph Pharmaceutical Stock Co Ltd capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see Henan Taloph Pharmaceutical Stock Co Ltd (600222) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥47.16 Million | CN¥21.12 Million | ▼ -54.6% |
| 2023 | 0.99x | CN¥43.74 Million | CN¥43.13 Million | ▲ +151.5% |
| 2021 | 0.39x | CN¥99.66 Million | CN¥39.07 Million | ▼ -60.4% |
| 2020 | 0.99x | CN¥73.43 Million | CN¥72.65 Million | ▼ -61.8% |
| 2019 | 2.59x | CN¥41.53 Million | CN¥107.68 Million | ▲ +366.5% |
| 2018 | 0.56x | CN¥119.47 Million | CN¥66.41 Million | ▼ -71.0% |
| 2017 | 1.91x | CN¥23.17 Million | CN¥44.34 Million | ▲ +126.7% |
| 2016 | 0.84x | CN¥70.60 Million | CN¥59.60 Million | ▼ -33.0% |
| 2015 | 1.26x | CN¥49.27 Million | CN¥62.04 Million | ▲ +216.5% |
| 2014 | 0.40x | CN¥89.54 Million | CN¥35.62 Million | ▲ +133.4% |
| 2012 | 0.17x | CN¥87.45 Million | CN¥14.91 Million | ▼ -100.0% |
| 2011 | 612.28x | CN¥105.20K | CN¥64.41 Million | ▲ +46377.1% |
| 2009 | 1.32x | CN¥21.45 Million | CN¥28.25 Million | ▼ -41.7% |
| 2008 | 2.26x | CN¥18.13 Million | CN¥40.98 Million | ▲ +13.7% |
| 2007 | 1.99x | CN¥21.34 Million | CN¥42.42 Million | ▼ -91.4% |
| 2006 | 22.99x | CN¥1.59 Million | CN¥36.64 Million | ▼ -69.0% |
| 2005 | 74.04x | CN¥276.30K | CN¥20.46 Million | ▲ +8971.7% |
| 2004 | 0.82x | CN¥18.25 Million | CN¥14.90 Million | ▼ -81.9% |
| 2003 | 4.52x | CN¥3.74 Million | CN¥16.89 Million | ▲ +430.5% |
| 2002 | 0.85x | CN¥7.47 Million | CN¥6.36 Million | ▼ -20.2% |
| 2001 | 1.07x | CN¥55.03 Million | CN¥58.73 Million | ▼ -99.1% |
| 2000 | 123.50x | CN¥875.36K | CN¥108.11 Million | ▲ +15260.6% |
| 1999 | 0.80x | CN¥99.32 Million | CN¥79.86 Million | ▲ +63076.1% |
| 1998 | 0.00x | CN¥28.04 Million | CN¥35.69K | — |